ROWLAND MARCUS C - 05 Aug 2021 Form 4 Insider Report for MIND TECHNOLOGY, INC (MIND)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
09 Aug 2021, 16:31:00 UTC
Prior SEC filing
11 May 2021
Next SEC filing
24 Feb 2022
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Robert P. Capps, Attorney-in-Fact for Marcus C. Rowland

Key filing fact

ROWLAND MARCUS C filed Form 4 for MIND TECHNOLOGY, INC (MIND) on 09 Aug 2021.

Key facts

  • This page summarizes ROWLAND MARCUS C's Form 4 filing for MIND TECHNOLOGY, INC (MIND).
  • 1 reported transaction and 1 derivative row are listed below.
  • Accepted by SEC: 09 Aug 2021, 16:31.

Change

  • Previous filing in this sequence was filed on 11 May 2021.
  • Current net transaction value: +$88,650.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

MIND transaction Derivative

Option to Purchase Common Stock

Award

Transaction value
$88,650
Shares
+45,000
Change %
Price
$1.97
Shares after
45,000
Date
05 Aug 2021
Ownership
Direct
Underlying class
MIND Common Stock
Underlying amount
45,000
Exercise price
$1.97
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

1. Options vest 1/3 on August 5, 2022, 1/3 on August 5, 2023 and 1/3 on August 5, 2024.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .